Variations in (123)I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

BACKGROUND: There is lack of validation and standardisation of acquisition parameters for myocardial (123)I-metaiodobenzylguanidine (MIBG). This lack of standardisation hampers large scale implementation of (123)I-MIBG parameters in the evaluation of patients with chronic heart failure (CHF). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Verberne, Hein J., Habraken, Jan B. A., van Eck-Smit, Berthe L. F., Agostini, Denis, Jacobson, Arnold F.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275776/
https://www.ncbi.nlm.nih.gov/pubmed/17922122
http://dx.doi.org/10.1007/s00259-007-0611-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275776/
https://www.ncbi.nlm.nih.gov/pubmed/17922122
http://dx.doi.org/10.1007/s00259-007-0611-2

Ejemplares similares